TGF-β skews the differentiation of CD4- T cells to T helper (Th)17 polarization rather than Th1 cells, reducing the activation of effector CD8- T cell and inducing tumour-promoting inflammation (22, 42–44). The gene discussed is TGFB1; the disease is neoplasm.